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ABSTRACT
Background: Total serum IgE may be increased in
alcoholics. IgE synthesis depends on B cell activation
by Th2-type cytokines. Serum sCD30 has been pro-
posed as a marker of Th2 responses. The aim of the
present study was to evaluate serum sCD30 levels in
alcoholics and their relationship with serum IgE values.
Methods: Twenty-five active alcoholics and 18 healthy
controls were included in the study. All subjects were
non-atopic (asymptomatic from the allergologic point
of view and Phadiatop® (Phamacia & Upjohn Diag-
nostics AB, Uppsala, Sweden) negative). Serum IgE was
measured by chemiluminescent enzyme immunoassay
and serum sCD30 was assayed by ELISA.
Results: Total serum IgE was higher in alcoholics than
in controls (median (range) for alcoholics and controls
59 (15.8–236) vs 24 (4–103) IU/mL, respectively; 
P = 0.003). Conversely, median serum sCD30 levels
were lower in alcoholics than in controls (< 1 (< 1–144)
vs 7.3 (< 1–83) U/mL, respectively; P = 0.02). Among
the alcoholics, a negative correlation between serum
IgE and sCD30 values was observed.
Conclusions: Increased serum IgE in non-atopic alco-
holics is associated with low serum sCD30 concentra-
tions. In so far as sCD30 is a marker of Th2 activation,
total serum IgE elevation in alcoholics does not seem
to be related to Th2 dominance.
Key words: alcohol, IgE, Ki-1, sCD30.
INTRODUCTION
CD30 is a cytokine receptor that was originally described
as the surface molecule recognized by the Ki-1 mono-
clonal antibody in Hodgkin’s and Reed–Sternberg cells,
as well as in a variety of non-Hodgkin’s lymphomas.1 The
extracellular portion of CD30 can be split to produce an
88 kDa soluble form of the molecule (sCD30), which is
released by CD30-expressing cells.2 Membrane CD30 is
preferentially expressed (and, therefore, sCD30 released)
by human T cells producing Th2-type cytokines.3,4 More-
over, sCD30 has been proposed as a marker of Th2-type
responses in vivo.3,4
IgE synthesis needs Th2-type cytokine (particularly inter-
leukin (IL)-4 and IL-13) action on B cells and, therefore,
conditions involving increased IgE levels are suggestive 
of Th2 cytokine predominance.5 Accordingly, many Th2-
driven disorders, such as atopy, Hodgkin’s disease, human
immunodeficiency virus (HIV) infection, infectious mono-
nucleosis, measles, chronic hepatitis B, systemic lupus
erythematosus, bullous pemphigoid and Ommenn’s syn-
drome, are characterized by both increased total serum IgE
levels6 and increased serum sCD30 concentrations.7–15
Alcoholism is associated with increased total serum
IgE levels.16–20 Ethanol intake in mothers is related to
elevated cord blood IgE levels in their offspring.21 Experi-
mental ethanol administration in mice induces an increase
in IgE.22 Alcohol abuse is accompanied by profound alter-
ations of the cytokine balance.19,20,23 It could be suggested
that a Th2-predominance was responsible for increased
serum IgE levels in alcoholics. The aim of the present study
was to evaluate the possible correlation between serum
IgE values and sCD30 levels in alcoholics.
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METHODS
Subjects
Twenty-five patients (21 males; 84%) with a median age
of 41 years (range 30–70 years) entered the study. 
All were admitted to hospital with ethanol withdrawal
symptoms. They were chronic alcohol abusers, with an
average alcohol intake of more than 120 g/day for a
minimum of 5 years up to 24–48 h before admission.
Ten (40%) were current smokers. Eighteen healthy volun-
teers (personnel and students from our center), aged
22–60 years, 15 males (83%), with an average alcohol
intake lower than 30 g/week, were used as controls. Six
healthy controls (33%) were smokers.
All patients and controls included in this study were
non-atopic. They denied a present or past history of
allergic diseases and had a negative serum UniCAPTM–
Phadiatop® test (Phamacia & Upjohn Diagnostics AB,
Uppsala, Sweden). Phadiatop® is a single serologic test
(qualitative fluoroenzymeimmunoassay) for the differen-
tial determination of specific IgE antibodies to common
inhalant allergens, which evaluates the overall degree
of sensitization to these allergens. It may be a useful
tool to classify individuals as atopics or non-atopics in
epidemiologic studies with a particularly high negative
predictive value.24 Other known causes of either IgE
increase or sCD30 elevation were absent in all subjects
studied.
Procedures
Samples of sera were taken during the first 24 h of the
hospital stay and stored at –80°C until tested. Serum
sCD30 values were assayed by means of a commercially
available ELISA kit (Dako CD30; DAKO A/S, Glostrup,
Denmark). The lowest detection limit of the assay was 
1 U/mL. Total serum IgE was measured by a chemi-
luminescent enzyme immunoassay (ImmuliteTM; Diag-
nostic Products, Los Angeles, CA, USA). The lowest
detection limit for total serum IgE was 2 IU/mL. Routine
serum biochemical parameters in alcoholics were
assayed in a Hitachi 747 autoanalyzer (Boehringer-
Mannheim, Mannheim, Germany).
Ethical issues
The study was performed in accordance with the princi-
ples of the 1975 Declaration of Helsinki and was
approved by the local Research Committee.
Statistical analysis
The Chi-squared test was used to compare dichotomous
variables. The two-tailed Mann–Whitney U-test was used
to compare continuous variables, because most of them
did not fulfill criteria of normality. For the same reason,
Spearman’s rank test was used for bivariate correlation.
For statistical analysis, values below the aforementioned
levels of detection were considered as zero. P < 0.05
was considered statistically significant.
RESULTS
Serum IgE and sCD30 concentrations in alcoholics and
controls are shown in Fig. 1. Total serum IgE levels were
higher in alcoholics than in controls (median (range)
Fig. 1 Serum levels (log) of (a) total IgE and (b) sCD30 in
alcoholics and healthy controls. Horizontal solid lines represent
median values. Horizontal dashed lines represent the lower ref-
erence threshold levels.
values of 59 (15.8–236) vs 24 (4–103) IU/mL, respec-
tively; P = 0.003). Conversely, serum sCD30 levels were
lower in alcoholics than in controls (< 1 (< 1–144) 
vs 7.3 (< 1–83) U/mL, respectively; P = 0.02). Fifteen
alcoholics (60%) had undetectable serum sCD30 levels
compared with only one control (5%; P < 0.001). A
comparison of epidemiologic and biologic data between
alcoholic patients with detectable and undetectable
sCD30 values is given in Table 1. Age, gender, smoking
habit and liver function tests were similar in patients with
detectable and undetectable sCD30 concentrations.
Serum IgE values were significantly higher in cases with
undetectable sCD30 concentrations (Table 1). Serum
sCD30 levels showed a weak but statistically significant
negative correlation with serum IgE concentrations 
(r = –0.40; P = 0.008). Such a correlation was observed
in the group of alcoholics (r = –0.48; P = 0.01), but not
in the control group (r = 0.10; P = 0.6).
DISCUSSION
Previous studies have demonstrated that serum IgE is
elevated in alcoholics, independent of age, gender,
smoking, nutritional status, liver function or parasite
infestation.18–22 However, most of these studies classi-
fied patients as atopic or non-atopic only by clinical
history.16–19 Atopy affects as much as 30% of the popula-
tion and is associated with Th2 dominance and increased
serum concentrations of both sCD30 and IgE.7 In the
present study, increased serum IgE was confirmed in 
a group of non-atopic (clinically asymptomatic and
Phadiatop® negative) alcoholics. Similar results were
obtained when alcoholics were stratified as atopics or
non-atopics by means of skin prick tests.20
A Th2-cytokine predominance could be a hypothesis
for IgE increase in alcoholics. Total serum IgE increase in
alcoholics was found to be associated with elevated cir-
culating levels of IL-10 and IL-13.19 However, Laso et al.
demonstrated that peripheral blood T cells from active
alcoholics produce increased quantities of interferon-γ,
the main Th1 cytokine.25 Similarly, we observed that
increased IgE in alcoholics is associated with a paradoxi-
cally low production of IL-4, the main Th2 cytokine.20
Furthermore, alcoholics show increased levels of IL-12,19
the main promoter of Th1 development. Here, increased
IgE in non-atopic alcoholics was associated with low
serum sCD30 levels. Low serum sCD30 values in alco-
holics could be due to either downregulated CD30
expression or decreased sCD30 release. The number of
peripheral blood CD30+ cells was not evaluated. With
this limitation, low sCD30 levels would confirm a
decreased Th2 activation and, therefore, a Th1 predomi-
nance in this group of patients. However, although it is
generally assumed that CD30 expression/sCD30 release
represents Th2 activation, some reports conclude that
CD30 may not be an exclusive marker for Th2-type
responses.26 Increased serum sCD30 values have been
found in Th1-driven conditions, such as rheumatoid
arthritis and Wegener’s granulomatosis.26 In Th2-medi-
ated conditions, sCD30 could be a marker of disease
activity, while in Th1-mediated diseases CD30-positive
cells would exert an anti-inflammatory counter-regulatory
activity.26 The Th1/Th2 dichotomy is more evident in the
mouse than it is in the human and, as Gerli et al. pointed
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Table 1 Epidemiologic and biologic data in alcoholic patients with detectable (≥ 1 U/mL) and undetectable (< 1 U/mL) sCD30
values
Detectable sCD30 Undetectable sCD30 P
(n = 10) (n = 15)
Age (years) 48 (30–60) 41 (31–70) 0.9
No. males (%) 7 (70) 14 (93) 0.3
No. smokers (%) 4 (40) 6 (40) 1
Serum albumin (g/dL) 3.7 (2.2–4.7) 3.8 (3.0–4.8) 0.7
Serum bilirubin (mg/dL) 1.2 (0.3–7.4) 1.4 (0.5–15.9) 0.6
Serum AST (U/L) 68 (14–107) 50 (14–226) 0.9
Serum ALT (U/L) 46 (19–80) 31 (11–182) 0.3
Serum GGT (U/L) 237 (52–3850) 95 (19–997) 0.1
Prothrombin index (%) 96 (50–100) 100 (59–100) 0.4
Total serum IgE (IU/mL) 28.3 (16–100) 64.8 (15.8–236) 0.01
Data are represented as the median and range in parentheses or as absolute values and percentages in parentheses.
The upper normal reference values for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and glutamyl transpeptidase (GGT) are
28, 29 and 32 U/L, respectively.
out, the concept of Th1 or Th2 predominance in a partic-
ular disease should not be overemphasized, because
either subset may play a dynamic role modulating the
immune response over time.26 Alcoholism is such an
example, because it is associated with both Th1- and
Th2-driven phenomena, as mentioned previously. The
mechanisms for these simultaneous Th1 and Th2 phe-
nomena in alcoholics are unknown. Endotoxemia, which
is common after ethanol intake,27 could drive both Th1
and Th2 development,28 including IgE synthesis,29 but this
hypothesis needs further investigation.
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